BAXTER SUPPORTS NEW STUDY SHOWING BLOOD PURIFICATION WITH OXIRIS FILTER SET CAN PLAY A ROLE IN THE MANAGEMENT OF SEVERELY ILL COVID-19 PATIENTS ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received emergency use authorization (EUA) from the U.S. FDA for the company’s ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus that emerged in December 2019 in Wuhan, China, and is the cause of coronavirus disease 2019 (COVID-19) pandemic.

Extracorporeal blood purification shows early promise for reducing the risk of cardiac surgery-associated acute kidney injury. Extracorporeal blood purification may reduce the risk of cardiac ...